C07K 14/645
Secretins
C07K14/645 (Secretins) appears on 47 US grants and 59 published applications in this corpus.
Search patents in C07K- Granted patents
- 47
- Published applications
- 59
- Assignees
- 42
- Inventors
- 160
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 2 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 2 |
| 2011 | 1 | 3 |
| 2012 | 0 | 1 |
| 2013 | 2 | 1 |
| 2014 | 1 | 2 |
| 2015 | 3 | 4 |
| 2016 | 3 | 3 |
| 2017 | 1 | 4 |
| 2018 | 3 | 2 |
| 2019 | 2 | 4 |
| 2020 | 2 | 5 |
| 2021 | 2 | 1 |
| 2022 | 1 | 3 |
| 2023 | 2 | 3 |
| 2024 | 1 | 8 |
| 2025 | 4 | 5 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Fusion protein having triple activity and use thereof8 Sep 2026US 12,729,231 B2Shanghai Minwei Biotechnology Co., LTD
- Fusion proteins for the treatment of cardiometabolic diseases9 Dec 2025US 12,492,236 B2Shattuck Labs, Inc.
- Fusion protein including GIP and FGF21 and compositions thereof24 Jun 2025US 12,338,271 B2Jiangnan University
- Modified GIP peptide analogues13 May 2025US 12,297,250 B2Antag Therapeutics ApS
- Modified GIP peptide analogues7 Jan 2025US 12,187,773 B2Antag Therapeutics ApS
- Peptide targeting gip and glp-2 receptors for treating bone disorders10 Sep 2026US 2026/0265333 A1Centre Hospitalier Universitaire D'Angers
- Fusion protein having triple activity and use thereof25 Jun 2026US 2026/0176323 A1Shanghai Minwei Biotechnology Co., LTD
- Fusion protein having triple activity and use thereof7 May 2026US 2026/0125444 A1Shanghai Minwei Biotechnology Co., LTD
- Modified gip peptide analogues11 Dec 2025US 2025/0376499 A1Antag Therapeutics ApS
- Optimized GIP Peptide Analogues13 Nov 2025US 2025/0346647 A2Antag Therapeutics ApS
Most cited
By later US patents
- Conformationally restricted biologically active peptides, methods for their production and uses thereof89US 5,364,851 AInternational Synthecon, LLC · 1994
- Hair growth composition29US 5,091,173 AUniversity of Dundee · 1992
- GIP-GLP-1 dual agonist compounds and methods15US 10,093,713 B2Zealand Pharma A/S · 2018
- Process for purifying secretin12US 4,533,494 AEisai Co., Ltd. · 1985
- Preparation of secretin12US 4,711,847 A501 Hoechst Aktiengesellschaft · 1987